Fulcrum Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 789 $12.43 $9,806
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 9,211 $12.14 $111,775
Option
THOMSON PETER G. officer: VP Finance & Accounting
 Common Stock 5,000 $7.84 $39,200
Sale
THOMSON PETER G. officer: VP Finance & Accounting
 Common Stock 5,000 $7.84 $39,200
Option
THOMSON PETER G. officer: VP Finance & Accounting
 Stock Option (right to buy) 5,000 $7.84 $39,200
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 8,215 $14.38 $118,107
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 8,215 $14.38 $118,107
Sale
THOMSON PETER G. officer: VP Finance & Accounting
 Common Stock 6,607 $14 $92,498
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 10,000 $12.08 $120,830
Option
WALLACE OWEN B. officer: Chief Scientific Officer
 Common Stock 6,350 $7.84 $49,784
Option
WALLACE OWEN B. officer: Chief Scientific Officer
 Stock Option (right to buy) 6,350 $7.84 $49,784
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 2,500 $20 $50,000
Option
WALLACE OWEN B. officer: Chief Scientific Officer
 Common Stock 2,951 $7.84 $23,136
Sale
WALLACE OWEN B. officer: Chief Scientific Officer
 Common Stock 2,951 $7.84 $23,136
Option
WALLACE OWEN B. officer: Chief Scientific Officer
 Stock Option (right to buy) 2,951 $7.84 $23,136
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 1,071 $18.3 $19,599
Option
WALLACE OWEN B. officer: Chief Scientific Officer
 Common Stock 141 $7.84 $1,105
Sale
WALLACE OWEN B. officer: Chief Scientific Officer
 Common Stock 141 $7.84 $1,105
Option
WALLACE OWEN B. officer: Chief Scientific Officer
 Stock Option (right to buy) 141 $7.84 $1,105
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 2,500 $20.8 $51,993
Option
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 1,459 $4.83 $7,047
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 1,459 $4.83 $7,047
Option
CADAVID DIEGO officer: SVP Clinical Development
 Stock Option (right to buy) 1,459 $4.83 $7,047
Option
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 401 $4.83 $1,937
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 401 $4.83 $1,937
Option
CADAVID DIEGO officer: SVP Clinical Development
 Stock Option (right to buy) 401 $4.83 $1,937
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 156 $20 $3,120
Option
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 451 $20.18 $9,101
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 451 $20.18 $9,101
Option
CADAVID DIEGO officer: SVP Clinical Development
 Stock Option (right to buy) 451 $20.18 $9,101
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 3,433 $20.17 $69,250
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 1,300 $20.05 $26,059
Option
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 226 $4.83 $1,092
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 226 $4.83 $1,092
Option
CADAVID DIEGO officer: SVP Clinical Development
 Stock Option (right to buy) 226 $4.83 $1,092
Option
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 338 $20.18 $6,819
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 338 $20.18 $6,819
Option
CADAVID DIEGO officer: SVP Clinical Development
 Stock Option (right to buy) 338 $20.18 $6,819
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 1,500 $20.13 $30,192
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 2,797 $20 $55,940
Option
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 45 $4.83 $217
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 45 $4.83 $217
Option
CADAVID DIEGO officer: SVP Clinical Development
 Stock Option (right to buy) 45 $4.83 $217
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 5 $20 $100
Sale
GOULD ROBERT J director, officer: See Remarks
 Common Stock 1,390 $20.08 $27,911
Option
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 200 $20.04 $4,007
Sale
CADAVID DIEGO officer: SVP Clinical Development
 Common Stock 200 $20.04 $4,007
Option
CADAVID DIEGO officer: SVP Clinical Development
 Stock Option (right to buy) 200 $20.04 $4,007
Option
WALLACE OWEN B. officer: Chief Scientific Officer
 Common Stock 2,232 $7.84 $17,499
Sale
WALLACE OWEN B. officer: Chief Scientific Officer
 Common Stock 2,232 $7.84 $17,499

Showing 50 to 100 of 130 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: